Practice-Based Intervention for Urinary Incontinence
(OPTIMA Trial)
Trial Summary
What is the purpose of this trial?
The main goal of this clinical trial is to improve the care for urinary incontinence (UI) provided to adult women by primary care providers. The main questions it aims to answer are: * Can a practice-based intervention involving primary care providers lead to improved quality of incontinence care? * Will this intervention reduce the utilization of specialist care for urinary incontinence? * What effect will this intervention have on patient outcomes, including disease-specific outcomes, symptom severity, quality of life, and patient knowledge? * Does our intervention reduce disparities in care? Provider participants will be randomized at the office level to either an intervention group or a delayed intervention (control) group. The intervention group will receive an intervention consisting of academic detailing, clinical decision support tools, electronic referral, and the ability to refer to an advanced practice provider for co-management. The delayed intervention group will provide usual care until the crossover phase of the study, at which point they will receive the same intervention as the intervention group. Patient participants will bring up urinary incontinence with their primary care provider and complete three electronic surveys. Researchers will compare the intervention group to the delayed intervention (control) group to see if the intervention results in increased adherence to evidence-based quality indicators.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your primary care provider.
What data supports the effectiveness of the treatment Practice-Based Intervention for Urinary Incontinence?
Research shows that computer-based clinical decision support systems (CDS) can improve patient outcomes by helping healthcare providers make better decisions. These systems are effective in various clinical settings, suggesting they could also benefit treatments for urinary incontinence by providing timely, patient-specific recommendations.12345
Is the practice-based intervention for urinary incontinence safe for humans?
How is the Practice-Based Intervention for Urinary Incontinence treatment different from other treatments?
This treatment is unique because it combines several modern healthcare tools like electronic clinical decision support, electronic referrals, and co-management with advanced practice providers to improve care for urinary incontinence. Unlike traditional treatments, it leverages technology and collaborative care to enhance decision-making and streamline patient management.110111213
Eligibility Criteria
This trial is for adult women over 18 who speak English or Spanish and have urinary incontinence. They must confirm their condition with a screening tool and agree to participate. Primary care physicians from certain sites can also join, provided they're part of the recruited offices.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Implementation of a practice-based intervention involving physician education, electronic decision support, and patient education/co-management by an advanced practice provider
Crossover Validation
Control group receives the intervention to validate improvements in patient care and outcomes
Follow-up
Participants are monitored for safety and effectiveness after intervention
Treatment Details
Interventions
- Academic Detailing
- APP Co-management
- Electronic Clinical Decision Support
- Electronic Referral
Academic Detailing is already approved in United States for the following indications:
- Improving quality of incontinence care
- Reducing utilization of specialist care for urinary incontinence
- Enhancing patient outcomes
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Diego
Lead Sponsor
RAND
Collaborator
Agency for Healthcare Research and Quality (AHRQ)
Collaborator
Cedars-Sinai Medical Center
Collaborator
University of California, Los Angeles
Collaborator
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Collaborator